Related references
Note: Only part of the references are listed.Internet-delivered cognitive behavioral therapy (iCBT) for common mental disorders and subsequent sickness absence: a systematic review and meta-analysis
Lina Udd-granat et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2023)
Screening for Adulthood ADHD and Comorbidities in a Tertiary Mental Health Center Using EarlyDetect: A Machine Learning-Based Pilot Study
Yang S. Liu et al.
JOURNAL OF ATTENTION DISORDERS (2023)
Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients
Pim Cuijpers et al.
WORLD PSYCHIATRY (2023)
The linkage of depressive and anxiety disorders with the expected labor market affiliation (ELMA): a longitudinal multi-state study of Danish employees
Jacob Pedersen et al.
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2023)
Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain
Miquel Roca et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2023)
Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study
Johan Lundberg et al.
JAMA PSYCHIATRY (2023)
Productivity loss and productivity loss costs to United States employers due to priority conditions: a systematic review
Sirikan Rojanasarot et al.
JOURNAL OF MEDICAL ECONOMICS (2023)
Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study
Gregory Mattingly et al.
FRONTIERS IN PSYCHIATRY (2023)
Towards a new approach to job-related distress: A three-sample study of the Occupational Depression Inventory
Renzo Bianchi et al.
STRESS AND HEALTH (2023)
Healthy Minds: Group Cognitive-Behavioral Intervention for Sustainable Return to Work After a Sick Leave Due to Depression
Marc Corbiere et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2022)
Clinical and societal burden of incident major depressive disorder: A population-wide cohort study in Stockholm
Johan Lundberg et al.
ACTA PSYCHIATRICA SCANDINAVICA (2022)
Examination of the MMPI-3 over-reporting scales in a forensic disability sample
Jessica L. Tylicki et al.
CLINICAL NEUROPSYCHOLOGIST (2022)
Disclosure dilemmas: how people with a mental health condition perceive and manage disclosure at work
Kate E. Toth et al.
DISABILITY AND REHABILITATION (2022)
Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder: a systematic review and network meta-analysis
Bing Cao et al.
CNS SPECTRUMS (2022)
Functional status and return to work in people with major depression: a 3-year national follow-up study
Jia-Pei Hong et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2022)
Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis
Saundra Jain et al.
BMC PSYCHIATRY (2022)
Impact of the COVID-19 pandemic on suicidal attempts and death rates: a systematic review
Malshani L. Pathirathna et al.
BMC PSYCHIATRY (2022)
Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder
Koichiro Watanabe et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2022)
Association of stigmatizing attitudes with people's opinion of depression as a valid reason for sickness absence: A Swedish vignette study
Monica Bertilsson et al.
WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION (2022)
Relationship between burnout and Major Depressive Disorder in health professionals: A HEAR report
Sidney Zisook et al.
JOURNAL OF AFFECTIVE DISORDERS (2022)
Trends in Effectiveness of Organizational eHealth Interventions in Addressing Employee Mental Health: Systematic Review and Meta-analysis
Elizabeth Stratton et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2022)
Testing the Pragmatic Effectiveness of a Consumer-Based Mindfulness Mobile App in the Workplace: Randomized Controlled Trial
Jennifer L. Huberty et al.
JMIR MHEALTH AND UHEALTH (2022)
Effects of the Anti-stigma Workplace Intervention Working Mind in a Canadian Health-Care Setting: A Cluster-Randomized Trial of Immediate Versus Delayed Implementation: Effets d'une intervention en milieu de travail anti-stigmates, l'Esprit au travail, dans un milieu canadien de soins de sante: un essai randomise en grappes d'une mise en œuvre immediate plutot que reportee
Keith S. Dobson et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2021)
Implicit and Explicit Attitudes of Employers Toward Hiring People Who Have Experienced Depression
Yvon Florence et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2021)
'The dual pandemic' of suicide and COVID-19: A biopsychosocial narrative of risks and prevention
Debanjan Banerjee et al.
PSYCHIATRY RESEARCH (2021)
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review
Jason Ng et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
From Burnout to Occupational Depression: Recent Developments in Research on Job-Related Distress and Occupational Health
Irvin Sam Schonfeld et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Is Burnout a Depressive Condition? A 14-Sample Meta-Analytic and Bifactor Analytic Study
Renzo Bianchi et al.
CLINICAL PSYCHOLOGICAL SCIENCE (2021)
Digital mHealth Interventions for Employees Systematic Review and Meta-Analysis of Their Effects on Workplace Outcomes
Elizabeth Stratton et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2021)
Functional limitations in people with multimorbidity and the association with mental health conditions: Baseline data from the Canadian Longitudinal Study on Aging (CLSA)
Kathryn Fisher et al.
PLOS ONE (2021)
The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence
Nelson B. Rodrigues et al.
PSYCHIATRY RESEARCH (2021)
An Ecological Study of a Universal Employee Depression Awareness and Stigma Reduction Intervention: Right Direction
Benjamin Doty et al.
FRONTIERS IN PSYCHIATRY (2021)
Anxiety and Depression in Canada During the COVID-19 Pandemic: A National Survey
David J. A. Dozois
CANADIAN PSYCHOLOGY-PSYCHOLOGIE CANADIENNE (2021)
A Systematic Search and Review of Questionnaires Measuring Individual psychosocial Factors Predicting Return to Work After Musculoskeletal and Common Mental Disorders
Andrea Gragnano et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2021)
Tools Appraisal of Organizational Factors Associated with Return-to-Work in Workers on Sick Leave Due to Musculoskeletal and Common Mental Disorders: A Systematic Search and Review
Patrizia Villotti et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2021)
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Reseau Canadien Pour Les Traitements De L'humeur Et De L'anxiete (Canmat) Concernant L'utilisation De La Ketamine Racemique Chez Les Adultes Souffrant De Trouble Depressif Majeur
Jennifer Swainson et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2021)
Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine
Jean Lachaine et al.
CNS SPECTRUMS (2020)
Workplace bullying, mental distress, and sickness absence: the protective role of social support
Morten Birkeland Nielsen et al.
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2020)
Epidemiology of physical and mental comorbidity in Canada and implications for health-related quality of life, suicidal ideation, and healthcare utilization: A nationwide cross-sectional study
Haijiang Dai et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Improvements in Workplace Productivity in Working Patients With Major Depressive Disorder Results From the AtWoRC Study
Pratap Chokka et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2020)
Preventing suicide in the context of the COVID-19 pandemic
Roger S. McIntyre et al.
WORLD PSYCHIATRY (2020)
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder: A Systematic Review and Meta-analysis
Caroline S. Duchaine et al.
JAMA PSYCHIATRY (2020)
Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States
Eric Armbrecht et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020
Mark É. Czeisler et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Projected increases in suicide in Canada as a consequence of COVID-19
Roger S. McIntyre et al.
PSYCHIATRY RESEARCH (2020)
Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic
Catherine K. Ettman et al.
JAMA NETWORK OPEN (2020)
What Could Influence Workers' Decisions to Disclose a Mental Illness at Work?
Carolyn S. Dewa et al.
INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2020)
The Occupational Depression Inventory: A new tool for clinicians and epidemiologists
Renzo Bianchi et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2020)
Stakeholders' Role and Actions in the Return-to-Work Process of Workers on Sick-Leave Due to Common Mental Disorders: A Scoping Review
Marc Corbiere et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2020)
To Disclose or Not to Disclose: A Multi-stakeholder Focus Group Study on Mental Health Issues in the Work Environment
E. P. M. Brouwers et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2020)
Interventions to improve return to work in depressed people
Karen Nieuwenhuijsen et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)
Pratap Chokka et al.
CNS SPECTRUMS (2019)
Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study
Pratap Chokka et al.
CNS SPECTRUMS (2019)
Validation of the University of California San Diego Performance-based Skills Assessment (UPSA) in major depressive disorder: Replication and extension of initial findings
Michael Cronquist Christensen et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
The Working Mind: A Meta-Analysis of a Workplace Mental Health and Stigma Reduction Program
Keith S. Dobson et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2019)
What are they returning to? Psychosocial work environment as a predictor of returning to work among employees in treatment for common mental disorders: A prospective observational pre-post study
Bjorn Lau et al.
PLOS ONE (2019)
Is burn-out finally a disease or not?
Quentin V. Durand-Moreau
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2019)
Psychological treatments for return to work in individuals on sickness absence due to common mental disorders or musculoskeletal disorders: a systematic review and meta-analysis of randomized-controlled trials
Anna Finnes et al.
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2019)
Sustainable Return to Work: A Systematic Review Focusing on Personal and Social Factors
Abasiama Etuknwa et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2019)
Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
Josep Maria Haro et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)
A systematic review of work accommodations for people with mental disorders
Nayab Zafar et al.
WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION (2019)
Malingering and factitious disorder
Christopher Bass et al.
PRACTICAL NEUROLOGY (2019)
The Relationship Between Burnout, Depression, and Anxiety: A Systematic Review and Meta-Analysis
Panagiota Koutsimani et al.
FRONTIERS IN PSYCHOLOGY (2019)
Subjective Cognitive Decline Correlates With Depression Symptoms and Not With Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults
Zvinka Z. Zlatar et al.
JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES (2018)
Patterns of association of chronic medical conditions and major depression
S. B. Patten et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2018)
Effects of internet-based cognitive behavioural therapy and physical exercise on sick leave and employment in primary care patients with depression: two subgroup analyses
Viktor Kaldo et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2018)
Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome
Roxanne Gaspersz et al.
CURRENT OPINION IN PSYCHIATRY (2018)
Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review
Yena Lee et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Sickness absence: a systematic review and meta-analysis of psychological treatments for individuals on sick leave due to common mental disorders
Sigrid Salomonsson et al.
PSYCHOLOGICAL MEDICINE (2018)
Psychiatric diagnosis and other predictors of experienced and anticipated workplace discrimination and concealment of mental illness among mental health service users in England
Yusaku Yoshimura et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2018)
Prevention of Common Mental Disorders in Employees. Perspectives on Collaboration from Three Health Care Professions
Eva Rothermund et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
The Detection of Malingering: A New Tool to Identify Made-Up Depression
Merylin Monaro et al.
FRONTIERS IN PSYCHIATRY (2018)
Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers
John E. Harrison et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2018)
The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review
Olivia R. Cambridge et al.
PSYCHIATRY RESEARCH (2018)
How Can Supervisors Contribute to the Return to Work of Employees Who have Experienced Depression?
Alessia Negrini et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2018)
Determinants of Sickness Absence and Return to Work Among Employees with Common Mental Disorders: A Scoping Review
Haitze de Vries et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2018)
Effectiveness of Workplace Interventions in Return-to-Work for Musculoskeletal, Pain-Related and Mental Health Conditions: An Update of the Evidence and Messages for Practitioners
K. L. Cullen et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2018)
Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
Lene Hammer-Helmich et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Critical factors for the return-to-work process among people with affective disorders: Voices from two vocational approaches
Susann Porter et al.
WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION (2018)
Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder
Raymond W. Lam et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis
K. Kamenov et al.
PSYCHOLOGICAL MEDICINE (2017)
Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder
Danielle S. Cha et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Restoring function in major depressive disorder: A systematic review
David V. Sheehan et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
eThe THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disordere
Roger S. McIntyre et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Improving Employee Well-Being and Effectiveness: Systematic Review and Meta-Analysis of Web-Based Psychological Interventions Delivered in the Workplace
Stephany Carolan et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2017)
Internal consistency and concurrent validity of the Montreal Cognitive Assessment in individuals with major depressive disorder
Manit Srisurapanont et al.
PSYCHIATRY RESEARCH (2017)
Discrepancy between objective and subjective cognition in adults with major depressive disorder
Manit Srisurapanont et al.
SCIENTIFIC REPORTS (2017)
Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder
Yongjie Zhou et al.
SCIENTIFIC REPORTS (2017)
Work Accommodations and Natural Supports for Employees with Severe Mental Illness in Social Businesses: An International Comparison
Patrizia Villotti et al.
COMMUNITY MENTAL HEALTH JOURNAL (2017)
The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Joshua D. Rosenblat et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
F. Hieronymus et al.
MOLECULAR PSYCHIATRY (2016)
The effectiveness of interventions targeting the stigma of mental illness at the workplace: a systematic review
Sabine E. Hanisch et al.
BMC PSYCHIATRY (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments
Sagar V. Parikh et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H. Kennedy et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Vanessa C. Evans et al.
CNS DRUGS (2016)
Sustained efficacy of agomelatine 10 mg, 25 mg, and 25-50 mg on depressive symptoms and functional outcomes in patients with major depressive disorder. A placebo-controlled study over 6 months
Sidney H. Kennedy et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries
S. Evans-Lacko et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2016)
Understanding the burnout experience: recent research and its implications for psychiatry
Christina Maslach et al.
WORLD PSYCHIATRY (2016)
How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence
Pim Cuijpers et al.
WORLD PSYCHIATRY (2016)
Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients
Young Sup Woo et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2016)
Scaling-up treatment of depression and anxiety: a global return on investment analysis
Dan Chisholm et al.
LANCET PSYCHIATRY (2016)
Comparative effectiveness of psychological treatments for depressive disorders in primary care: network meta-analysis
Klaus Linde et al.
BMC FAMILY PRACTICE (2015)
A systematic review including meta-analysis of work environment and depressive symptoms
Tores Theorell et al.
BMC PUBLIC HEALTH (2015)
Physical exercise and internet-based cognitive-behavioural therapy in the treatment of depression: randomised controlled trial
Mats Hallgren et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Depression and Employment Status in Primary and Tertiary Care Settings
Sakina J. Rizvi et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2015)
The impact of cognitive impairment on perceived workforce performance: Results from the International Mood Disorders Collaborative Project
Roger S. McIntyre et al.
COMPREHENSIVE PSYCHIATRY (2015)
Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study
Gang Wang et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
DETECTION OF ANXIETY DISORDERS IN PRIMARY CARE: A META-ANALYSIS OF ASSISTED AND UNASSISTED DIAGNOSES
Elena Olariu et al.
DEPRESSION AND ANXIETY (2015)
Long-term work disability and absenteeism in anxiety and depressive disorders
Sanne M. Hendriks et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder
Atul R. Mahableshwarkar et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
Atul R. Mahableshwarkar et al.
NEUROPSYCHOPHARMACOLOGY (2015)
A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine
Stuart A. Montgomery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder
Jean-Philippe Boulenger et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder
Angelo Sambunaris et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study
David Bakish et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2014)
Factitious disorders and malingering: challenges for clinical assessment and management
Christopher Bass et al.
LANCET (2014)
The Impact of Job Accommodations on Employment Outcomes Among Individuals With Psychiatric Disabilities
Clifton M. Chow et al.
PSYCHIATRIC SERVICES (2014)
The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial
Joanna K. Soczynska et al.
PSYCHIATRY RESEARCH (2014)
Work Accommodations and Natural Supports for Maintaining Employment
Marc Corbiere et al.
PSYCHIATRIC REHABILITATION JOURNAL (2014)
A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder
Michael R. Liebowitz et al.
BMC PSYCHIATRY (2013)
A Meta-Analysis of Cognitive-Behavioural Therapy for Adult Depression, Alone and in Comparison With Other Treatments
Pim Cuijpers et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2013)
COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS
Roger S. McIntyre et al.
DEPRESSION AND ANXIETY (2013)
Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
Stuart A. Montgomery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Gregory M. Asnis et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Receiving Workplace Mental Health Accommodations and the Outcome of Mental Disorders in Employees With a Depressive and/or Anxiety Disorder
Carmelle Bolo et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2013)
Efficacy and Safety of Desvenlafaxine 25 and 50 Mg/Day in a Randomized, Placebo-Controlled Study of Depressed Outpatients
Nakao Iwata et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2013)
Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol
Tina Marie Myers Oakes et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
DEMO-II Trial. Aerobic Exercise versus Stretching Exercise in Patients with Major Depression-A Randomised Clinical Trial
Jesper Krogh et al.
PLOS ONE (2012)
A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical
Paula J. Gaynor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study
Paula J. Gaynor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Symptomatic and Functional Improvement in Employed Depressed Patients A Double-Blind Clinical Trial of Desvenlafaxine Versus Placebo
Boadie W. Dunlop et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Distinctive Clinical Characteristics and Suicidal Tendencies of Patients With Anxious Depression
Ho-Jun Seo et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2011)
Perceived Needs for and Use of Workplace Accommodations by Individuals With a Depressive and/or Anxiety Disorder
JianLi Wang et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2011)
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
Karen Hewett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review
David F. Tolin
CLINICAL PSYCHOLOGY REVIEW (2010)
The DEMO Trial: A Randomized, Parallel-Group, Observer-Blinded Clinical Trial of Strength Versus Aerobic Versus Relaxation Training for Patients With Mild to Moderate Depression
Jesper Krogh et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
K. Hewett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Clinical diagnosis of depression in primary care: a meta-analysis
Alex J. Mitchell et al.
LANCET (2009)
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
Maurizio Fava et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder
Michael R. Liebowitz et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial
Patrice Boyer et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Escitalopram and Duloxetine in Major Depressive Disorder A Pharmacoeconomic Comparison Using UK Cost Data
Alan G. Wade et al.
PHARMACOECONOMICS (2008)
A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder
A. Wade et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder
Bruno Fantino et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
Andrew A. Nierenberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
D. G. S. Perahia et al.
EUROPEAN PSYCHIATRY (2006)
Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
JL Fernandez et al.
PHARMACOECONOMICS (2005)
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
MJ Detke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2004)
The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care
R Romeo et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
An investigation of reasonable workplace accommodations for people with psychiatric disabilities: Quantitative findings from a multi-site study
KL MacDonald-Wilson et al.
COMMUNITY MENTAL HEALTH JOURNAL (2002)
The work limitations questionnaire
D Lerner et al.
MEDICAL CARE (2001)
Development and validation of a screening instrument for bipolar spectrum disorder: The mood disorder questionnaire
RMA Hirschfeld et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)